Patents by Inventor Ibrahim El-Deeb

Ibrahim El-Deeb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109886
    Abstract: The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and to pharmaceutical compositions comprising the compound. In Formula (I), rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 4, 2024
    Applicant: GRIFFITH UNIVERSITY
    Inventors: Mark VON ITZSTEIN, Ibrahim EL-DEEB, Patrice GUILLON, Larissa HEILIG
  • Publication number: 20220274965
    Abstract: The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I) In which R3 is selected from the group consisting of optionally substituted N-linked naphthotriazole, optionally substituted N-linked indazole, and certain N-linked triazoles. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection, and pharmaceutical compositions comprising the compounds.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Applicant: GRIFFITH UNIVERSITY
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Heilig, Patrice Guillon
  • Patent number: 10028938
    Abstract: The present invention relates to compounds which are found to exhibit an antiviral effect. The compounds are modulators of the activity of the viral haemagglutinin and/or neuraminidase enzymes.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: July 24, 2018
    Assignee: Griffith University
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Dirr, Patrice Guillon, Moritz Winger
  • Publication number: 20170290809
    Abstract: The present invention relates to compounds which are found to exhibit an antiviral effect. The compounds are modulators of the activity of the viral haemagglutinin and/or neuraminidase enzymes.
    Type: Application
    Filed: September 7, 2015
    Publication date: October 12, 2017
    Applicant: Griffith University
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Dirr, Patrice Guillon, Moritz Winger